Atlas Trials

Pilot Trial on Immunosuppression Modulation to Increase SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients

Clinical trial NCT05338177 · UNKNOWN

Trial details

NCT number
NCT05338177
Sponsor
Medical University of Vienna
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2021-11-15
Primary completion
2022-01-15
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.